INFANT AND FOLLOW UP FORMULA DIRECTIVE

WHEREAS, considering the vulnerability of infants and the potential health risks including severe infections associated with unsafe or poor quality infant formula, special formula and follow-up formulas; WHEREAS, following the national attention afforded to the promotion and protection of infants and child health, it is found essential to adequately regulate the safety quality, and promotion of infant, follow-up and special formulas; WHEREAS, that the encouragement and protection of breastfeeding is an important part of the health, nutrition and other social measures require to promote healthy growth and development of infants and young children ; and that breastfeeding is an important aspect of primary health care; WHEREAS, it is found essential to require infant formula, special formula and follow-up formulas to pass through a registration process, have market authorization and the person involved in trading these products to have a certificate of competence before products are made available to the public; NOW, THEREFORE, this directive is issued in accordance with Article 55 (3) of the Food, Medicine and Healthcare Administration and Control Proclamation No. 661/2009, and Article 98 of the Food, Medicine and Healthcare Administration and Control Regulation No.299/2013.